{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:35:19Z","timestamp":1790030119237,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvacx.2024.100539","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T02:37:08Z","timestamp":1722307028000},"page":"100539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of anti-phospholipid antibody titers before and after SARS-CoV-2 mRNA vaccination in hospital staff"],"prefix":"10.1016","volume":"20","author":[{"given":"Michi","family":"Hisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naho","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Sampei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Obikane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100539_b0005","unstructured":"World Health Organization (WHO). WHO Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201411 March 2020, https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [accessed on 15 May 2024]."},{"key":"10.1016\/j.jvacx.2024.100539_b0010","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/sji.12998","article-title":"Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management","volume":"93","author":"Anka","year":"2021","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jvacx.2024.100539_b0015","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1002\/iid3.807","article-title":"Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia","volume":"11","author":"Yasmin","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jvacx.2024.100539_b0020","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2024.100539_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102729","article-title":"Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward","volume":"20","author":"Le Joncour","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jvacx.2024.100539_b0030","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.41425","article-title":"Antiphospholipid Antibodies in Critically Ill Patients With COVID-19","volume":"72","author":"Xiao","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jvacx.2024.100539_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.774919","article-title":"Emotional Exhaustion of Burnout Among Medical Staff and Its Association With Mindfulness and Social Support: A Single Center Study During the COVID-19 Pandemic in Japan","volume":"13","author":"Sampei","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jvacx.2024.100539_b0040","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1038\/s41598-021-84387-3","article-title":"A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies","volume":"11","author":"Noda","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvacx.2024.100539_b0045","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0015-0282(99)00119-3","article-title":"Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses","volume":"71","author":"Sugi","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jvacx.2024.100539_b0050","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jvacx.2024.100539_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111953","article-title":"Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2","volume":"142","author":"Granados-Riveron","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jvacx.2024.100539_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2022.101402","article-title":"COVID-19 and antiphospholipid antibodies","volume":"35","author":"Butt","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jvacx.2024.100539_b0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12026-022-09309-5","article-title":"The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels","volume":"70","author":"Noureldine","year":"2022","journal-title":"Immunol Res"},{"key":"10.1016\/j.jvacx.2024.100539_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930074","article-title":"Anti-phospholipid antibodies and coronavirus disease 2019: vaccination does not trigger early autoantibody production in healthcare workers","volume":"13","author":"Borghi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2024.100539_b0075","doi-asserted-by":"crossref","first-page":"2229072","DOI":"10.1080\/08916934.2023.2229072","article-title":"The onset of de novo autoantibodies in healthcare workers after mRNA based anti-SARS-CoV-2 vaccines: a single centre prospective follow-up study","volume":"56","author":"Sacchi","year":"2023","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jvacx.2024.100539_b0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13104-022-06180-3","article-title":"SARS CoV- 2 vaccination induces antibodies against cardiolipin","volume":"15","author":"Krashias","year":"2022","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jvacx.2024.100539_b0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0049-3848(96)00165-X","article-title":"Autoantibodies to kininogen-phosphatidylethanolamine complexes augment thrombin-induced platelet aggregation","volume":"84","author":"Sugi","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvacx.2024.100539_b0090","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1470-2045(21)00574-X","article-title":"mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial","volume":"22","author":"Oosting","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T19:29:11Z","timestamp":1729020551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":18,"alternative-id":["S2590136224001128"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100539","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of anti-phospholipid antibody titers before and after SARS-CoV-2 mRNA vaccination in hospital staff","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100539"}}